Skip to main content
. 2021 Dec 17;22(24):13557. doi: 10.3390/ijms222413557

Figure 6.

Figure 6

Cell viability expressed as % of viable NHDF after contact with extracts of placebo (PL-graft) and tobramycin loaded grafts (TB0.2-graft), in comparison with the 100% cell viability of the control (Ctr).